Ipilimumab trials for Clinical Stage IV Cutaneous Melanoma AJCC v8

All Ipilimumab trials · All Clinical Stage IV Cutaneous Melanoma AJCC v8 trials

Phase breakdown

Recruiting trials studying Ipilimumab for Clinical Stage IV Cutaneous Melanoma AJCC v8

• A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
  NCT04511013 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 331 locations
• Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
  NCT05896839 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 26 locations
• Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
  NCT04697576 · Phase: Phase 1 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 1 location
• Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial
  NCT07155317 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

How many trials study Ipilimumab for Clinical Stage IV Cutaneous Melanoma AJCC v8?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.